Clinical Trial Update: Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 study reporting steady-state pharmacokinetics of ceftazidime/avibactam in patients with cystic fibrosis; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: University of Southern California | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2018-11-27